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ABSTRACT
Kinetoplastid mRNAs possess a unique hyper-
methylated cap 4 structure derived from the stan-
dard m
7GpppN cap structure, with 20-O methylations
on the first four ribose sugars and additional base
methylations on the first adenine and the fourth
uracil. While the enzymes responsible for m
7GpppN
cap 0 formations has been characterized in
Trypanosoma brucei, the mechanism of cap 4 methy-
lation and the role of the hypermethylated struc-
ture remain unclear. Here, we describe the
characterization of a 48 kDa T.brucei 20-O nucleo-
side methyltransferase (TbCom1). Recombinant
TbCom1 transfers the methyl group from S-
adenosylmethionine (AdoMet) to the 20-OH of the
second nucleoside of m
7GpppNpNp-RNA to form
m
7GpppNpNmp-RNA. TbCom1 is also capable of
converting cap 1 RNA to cap 2 RNA. The methyl
transfer reaction is dependent on the m
7GpppN
cap, as the enzyme does not form a stable interac-
tion with GpppN-terminated RNA. Mutational
analysis establishes that the TbCom1 and vaccinia
virus VP39 methyltransferases share mechanistic
similarities in AdoMet- and cap-recognition. Two
aromatic residues, Tyr18 and Tyr187, may partici-
pate in base-stacking interactions with the guanine
ring of the cap, as the removal of each of
these aromatic side-chains abolishes cap-specific
RNA-binding.
INTRODUCTION
The 50 cap of eukaryotic mRNAs is essential for protecting
mRNA from degradation and facilitating translation initia-
tion. The simplest cap structure, m7GpppN or cap 0, consists
of an N-7 methylated guanosine linked by a 50-50 triphosphate
bridge to the ﬁrst nucleoside of nascent transcripts. In higher
eukaryotes, including mRNAs from insects, vertebrates and
their viruses, cap 0 is further modiﬁed by the addition of
methyl groups to either the ribose or base moiety of the
ﬁrst and the second transcribed nucleosides [reviewed in
(1)]. Methylation at the 20-hydroxyl position of the ﬁrst tran-
scribed ribose is termed cap 1 (m
7GpppNm) and similar
methylation of the second transcribed position is termed
cap 2 (m
7GpppNmNm). While cap-speciﬁc 20-O nucleoside
RNA methyltransferases have been identiﬁed from viral
sources and the activity has been detected in mammalian
extracts (2–5), the signiﬁcance of the methylated cap struc-
ture and the role of these methyltransferases in cellular
mRNA metabolism remain largely unexplored.
Trypanosoma brucei and other related kinetoplastids pos-
ses a unique hypermethylated cap structure called cap 4,
which consists of a standard cap 0 with 20-O methylations
on the ﬁrst four ribose sugars (AmAmCmUm), and additional
base methylations on the ﬁrst adenine (m
6,6A) and the fourth
uracil (m
3U) (6,7). The cap 4 structure is formed exclusively
on the spliced leader (SL) RNA and is transferred to individ-
ual pre-mRNAs derived from a polycistronic transcript by
trans-splicing to form mature mRNAs (8–10). Analysis of
SL RNA biogenesis suggests that cap 4 is derived from cap
0 and is formed cotranscriptionally by sequential methylation
in a 50–30 direction, and that the methylation steps that lead to
cap 4 are required for the trans-splicing reaction (7,11,12).
Recently, a T.brucei nuclear cap-binding protein (TbCbc),
which facilitates mRNA maturation and translation, was
found to bind to cap 4 RNA with higher afﬁnity than cap 0
RNA (13). These ﬁndings suggest that cap 4 plays an impor-
tant role in mRNA biogenesis in trypanosomes, although it
does not appear to be required for SL RNA stability, ribonu-
cleoprotein particle assembly, or formation of SL RNA
secondary structure in vivo (12).
A comprehensive genomic sequence analysis of 20-O RNA
methyltransferase family members identiﬁed two open read-
ing frames in the T.brucei genome, Tb11.02.2500 (48 kDa)
and Tb09.211.3130 (57 kDa), that resemble the vaccina
virus VP39 protein (14). VP39 is a prototype of cap-
dependent 20-O nucleoside methyltransferase; it transfers a
methyl group from AdoMet to the ribose 20-OH of the ﬁrst
transcribed nucleoside of viral mRNA to form cap 1 (15).
Over twenty X-ray crystal structures of the VP39 protein
have been solved complexed with AdoMet, S-adenosyl-
homocysteine (AdoHcy), cap analogues and m
7Gppp(A)5
oligomers, as well as various methylated nucleotides
*To whom the correspondence should be addressed. Tel: +1 716 645 2363; Fax: +1 716 645 2975; Email: kiongho@buffalo.edu
  2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
5594–5602 Nucleic Acids Research, 2006, Vol. 34, No. 19 Published online 5 October 2006
doi:10.1093/nar/gkl573(16–20). Residues that contact AdoMet and the m
7G moiety
in the VP39 co-crystal structures are conserved in the
48 and 57 kDa T.brucei proteins, suggesting that these
T.brucei proteins may be responsible for SL RNA cap
4 formation.
In this study, we present biochemical characterization of
the 48 kDa T.brucei protein’s cap-dependent 20-O methyl-
transferase activity. We named this protein TbCom1 (T.brucei
cap 20-O methyltransferase) to denote the enzyme’s function.
TbCom1 homologs are encoded in Trypanosoma cruzi
(TcCom1) and Leishmania major (LmCom1) (Figure 1).
Recombinant TbCom1 binds speciﬁcally to m
7GpppN-
terminated RNA and catalyzes the transfer of a methyl
group from AdoMet to the 2nd transcribed nucleoside to
form m
7GpppNpNm. Mechanistic conservation between
VP39 and TbCom1 in AdoMet and cap 0 recognition is sug-
gested by structure-based mutational analysis of putative
AdoMet- and cap-binding residues.
MATERIALS AND METHODS
Cloning, expression and purification of
recombinant TbCom1
The Tb11.02.2500 (TbCOM1) open reading frame was ampli-
ﬁed by PCR from total Trypanosoma brucei brucei genomic
DNA (a gift from Laurie Read, SUNY Buffalo) using
oligonucleotide primers designed to introduce an NdeI
restriction site at the predicted translation start codon and a
BglII site 30 of the predicted stop codon. The 1.3 kb PCR
product was digested with NdeI and BglII and inserted into
pET16b (Novagen) to generate the plasmid pET-TbCOM1.
In this context, TbCOM1 is fused in frame with a 20 amino
acid N-terminal leader peptide containing 10 tandem his-
tidines and expression of the His-tagged protein is driven
by the T7 RNA polymerase promoter. The predicted amino
acid sequence of the 417 amino acid TbCom1 protein is
shown in Figure 1.
Alanine-substitution mutations were introduced into the
TbCOM1 gene by PCR using the two-stage overlap extension
method. The residues targeted for alanine-mutagenesis
include Tyr18, His74, Val115, Asp142, Arg144, Tyr187,
Asp192 and Glu253. The pET-TbCOM1 plasmid was used
as the template for the ﬁrst-stage ampliﬁcations. The DNA
products of the second-stage ampliﬁcation were digested
with NdeI and BglII and inserted into pET16b. The presence
of the desired mutation was conﬁrmed by DNA sequencing
analysis, and the presence of unwanted mutations was
excluded by sequencing the entire gene.
Wild-type and mutant pET-TbCOM1 were transformed
into Escherichia coli BL21(DE3) Gold (Novagen). A 2 l cul-
ture of E.coli BL21(DE3) Gold/pET-TbCOM1 was grown at
37 C in Luria–Bertani medium (LB medium) containing
0.1 mg/ml ampicillin until the OD600 reached 0.4. Isopropyl-
D-thiogalactopyranoside (IPTG) was added to 0.4 mM and
growth was continued at 17 C for 18 h. Cells were harvested
by centrifugation and stored at  80 C. All subsequent proce-
dures were performed at 4 C. Thawed bacteria were resus-
pended in 100 ml of Buffer A [50 mM Tris–HCl (pH 7.5),
10% sucrose and 0.25 M NaCl] and lysed by the addition
of lysozyme and Triton X-100 to ﬁnal concentrations of
100 mg/ml and 0.1%, respectively. The lysate was sonicated
to reduce viscosity, and insoluble material was removed by
centrifugation for 45 min at 14000 r.p.m. in a Beckman
TA14–50 rotor. The soluble extract was applied to a 5 ml col-
umn of Ni-NTA-agarose resin (Qiagen) that had been pre-
equilibrated with Buffer A containing 0.1% Triton X-100.
The column was washed with 50 ml of the same buffer and
eluted stepwise with 15 ml aliquots of Buffer B [50 mM
Tris–HCl (pH 8.0), 0.25 M NaCl and 10% glycerol] contain-
ing 0.05, 0.1, 0.2, 0.5 or 1 M imidazole. The polypeptide
composition of the column fractions was monitored by
SDS–PAGE. The His-tagged TbCom1 proteins adsorbed to
the column and were recovered in 0.1, 0.2 and 0.5 M imida-
zole eluates. These fractions were pooled and adjusted to
0.025 M NaCl by addition of Buffer C [50 mM Tris–HCl
(pH 8.0) and 10% glycerol], and then applied to a 5 ml col-
umn of diethylaminoethyl (DEAE) cellulose pre-equilibrated
in Buffer C containing 0.025 M NaCl. TbCom1 did not bind
to DEAE at low ionic strength but many of the bacterial
polypeptides were eliminated during this step. The DEAE
Figure 1. Sequence conservation among vaccinia and kinetoplastid cap-
dependent 20-O nucleoside methyltransferases. The amino acid sequences of
TbCom1 and T.cruzi (TcCom1: XP_81711), and L.major (LmCom1:
CAJ03958) homologs are aligned to the sequence of vaccinia virus VP39.
Side-chain identity in all proteins is highlighted by shaded boxes. Gaps in the
alignment are indicated by dashes. VP39 amino acid side-chains that contact
AdoMet or the m
7G cap are indicated by ‘a’ and ‘c’, respectively. The
secondary structure of VP39 is indicated below the aligned sequences. The b-
strands are depicted as arrows and a-helices as bars. TbCom1 residues that
were mutated to alanine in this study are denoted by asterisks above the
sequence.
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column pre-equilibrated in Buffer B with 0.025 M NaCl. The
column was washed with 50 ml of the same buffer and then
eluted stepwise with 15 ml of Buffer B containing 0.05, 0.1,
0.2, 0.3, 0.5 and 1.0 M NaCl. TbCom1 was recovered pre-
dominantly in the 0.2 M NaCl fraction ( 5 mg). The protein
sample was concentrated using Amicon-Ultra centrifugal
ﬁlter devices (Millipore) to 2.4 mg/ml, stored at  80 C and
thawed on ice just prior to use. Protein concentrations were
determined with the Bio-Rad dye reagent using BSA as the
standard.
Expression and purification of the vaccinia
virus VP39 protein
The VP39 expression plasmid, pET42a-J3R, was a generous
gift from Ed Niles (SUNY Buffalo). pET42a-J3R was intro-
duced into E.coli BL21(DE3) Gold and grown at 37 Ci nL B
medium containing 0.1 mg/ml ampicillin until the OD600
reached 0.4. The culture was adjusted to 0.4 mM IPTG and
incubation was continued for 4 h. VP39 was puriﬁed from
soluble bacterial lysate by one-step nickel-agarose chro-
matography. The 0.2 M imidazole eluate fractions containing
VP39 (2.8 mg/ml) were stored at  80 C and thawed on ice
just prior to use.
Preparation of RNA substrates
Triphosphate-terminated [a-
32P]GTP-labeled RNAs were
synthesized by in vitro transcription from PCR ampliﬁed lin-
ear DNA templates containing the T7 RNA polymerase pro-
moter in the presence of 2 mM [a-
32P]GTP, ATP, CTP and
UTP. RNAs were puriﬁed on a non-denaturing 8% polyacry-
lamide gel and eluted overnight in 10 mM Tris–HCl (pH 8.0),
1 mM EDTA, then precipitated with ethanol. The molar con-
centration of
32P-labeled RNA was calculated according to
the speciﬁc activity of the input [a-
32P]GTP. Fifty picomoles
of in vitro synthesized RNA were capped in a reaction mix-
ture (100 ml) containing 50 mM Tris–HCl (pH 8.0), 5 mM
DTT, 2.5 mM MgCl2,5 0mM AdoMet (Sigma), 50 mM
GTP, 100 pmol of mammalian capping enzyme (Mce1) and
100 pmol of recombinant yeast guanine N-7 methyltrans-
ferase (Abd1) at 30 C for 1 h (21,22). Proteins were removed
by phenol–chloroform (1:1) extraction and the m
7GpppRNAs
were recovered by ethanol precipitation. For preparation of
cap 1-terminated RNA (m
7GpppGmp-RNA), 100 pmol of
recombinant vaccinia VP39 was added to the above reaction.
Unmethylated capped RNA (GpppRNA) was prepared by
omitting Abd1 and AdoMet from the above reaction.
Cap methyltransferase assay
Standard reaction mixtures (10 ml) containing 50 mM Tris–
HCl (pH 7.5), 5 mM DTT, 1 pmol of either
32P-labeled
m
7GpppRNA (cap 0) or m
7GpppGmRNA (cap 1) and
4 pmol of TbCom1 were incubated for 30 min at 27 C.
The reaction mixtures were adjusted to 50 ml by addition of
50 mM Tris–HCl (pH 7.5) and 10 mg glycogen, and the
RNA was extracted by phenol–chloroform (1:1) followed
by ethanol precipitation. The pellet was resuspended in 10
ml of water and treated with either 140 ng nuclease P1 (US
Biologicals) in 50 mM sodium acetate (pH 5.5) or RNase
cocktail (330 ng of RNase A, 0.33 U of RNase T1 and
330 U of RNase T2) (Sigma) in 50 mM ammonium acetate
and 1 mM EDTA at 37 C for 16 h. While both nuclease P1
and RNase hydrolyze the phosphodiester bonds in RNA,
nuclease P1 generates 50 phosphate mononucleotides whereas
RNase generates 30 phosphate mononucleotides. Two micro-
liters of the above reactions were mixed with an equal vol-
ume of 90% formamide and 10 mM EDTA and the
products were resolved on denaturing 22% polyacrylamide
gels containing 7 M urea in 0.5· Tris–borate–EDTA. For
2D TLC analysis, 2 ml of the nuclease P1-digested products
were applied directly to cellulose-coated TLC plates (EMD
Biosciences) and developed in isobutyric acid:H2O:ammo-
nium hydroxide (66:33:1; v:v:v) as a ﬁrst dimension solvent
and 0.1 M sodium phosphate (pH 6.8):ammonium sulfate:1-
propanol (100:60:2; v:w:v) in the second-dimension solvent.
Radioactive products were visualized and quantitated with a
Storm 640 phosphorimager using ImageQuant software
(Molecular Dynamics).
Gel mobility shift assay
Standard binding mixtures (10 ml) containing 50 mM Tris–
HCl (pH 7.5), 5 mM DTT, 5% glycerol, 1 pmol of
32P-labeled
capped RNA and TbCom1 as speciﬁed were incubated at
room temperature for 15 min then on ice for 15 min. Binding
mixtures were applied to a 6% native polyacrylamide gel in
0.5· Tris–borate–EDTA buffer and run at 75 V at 4 C until
the bromophenol blue dye standard migrated  50% the
length of the gel. The complexes were detected by autoradio-
graphy of the dried gel and the extent of RNA-binding
(bound/[bound + free]) was quantitated by phosphorimager.
RESULTS
Cap-dependent RNA methyltransferase
activity of TbCom1
We expressed the TbCom1 protein in E.coli as a His10-tagged
fusion and puriﬁed from a soluble extract by adsorption to Ni-
agarose and phosphocellulose chromatography (Materials and
Methods). To evaluate whether recombinant TbCom1 pos-
sesses cap-dependent RNA methyltransferase activity, we
synthesized 35mer cap 0- and cap 1-terminated RNA sub-
strates that contain radiolabeled 50-phosphates only at the
ﬁrst four transcribed nucleosides, designated as cap 0 RNA-
IV and cap 1 RNA-IV, respectively (Figure 2). Digestion of
cap 0 RNA-IV with nuclease P1 followed by 2D TLC
resulted in two radiolabeled spots corresponding to pG and
m
7GpppG (Figure 2A). Note that the radioactivity of pGi s
derived from the 50-phosphate of nucleosides 2, 3 and
4 and thus the intensity is 3-fold greater than that of
m
7GpppG. We veriﬁed that the positions of these spots cor-
respond to pG and m
7GpppG by Ultraviolet (UV) shadowing
non-radioactive nucleoside 50-pG and m
7GpppG. Similarly,
digestion of cap 1 RNA-IV resulted in two radiolabeled
spots, corresponding to pG and m
7GpppGm (Figure 2C).
The m
7GpppGm migrated slightly faster than m
7GpppG in
the ﬁrst dimension due to methylation at position 1 of the
transcribed RNA.
Incubation of recombinant TbCom1 with cap 0 RNA-IV in
the presence of AdoMet followed by treatment with nuclease
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migrated faster than pG in the ﬁrst dimension (compare
Figure 2A and B). Approximately one-third of the pG radioac-
tivity was converted to the new radiolabeled species, whereas
the radioactivity of m
7GpppG remained constant. Based on the
published 2D map of methylated guanosine nucleotides (23),
we assigned this spot as pGm. An identical pGm spot was
detected when cap 1 RNA-IV was incubated with TbCom1
(Figure 2D), suggesting that TbCom1 is not methylating the
ﬁrst transcribed nucleoside. We surmise that TbCom1 is capa-
ble of modifying either cap 0 or cap 1 RNA.
TbCom1 methylates the 2nd position of
transcribed RNA
To determine the site of RNA methylation by TbCom1, we
synthesized three additional cap 0 RNAs containing radiola-
beled phosphates at positions 1, 2 and 3 of the transcribed
RNA (designated cap 0 RNA-I, -II and -III, respectively;
Figure 3A). TbCom1 was incubated with these capped
RNAs in the presence of AdoMet and then treated with either
nuclease P1 or an RNase cocktail. The digested products
were resolved on a high percentage denaturing polyacry-
lamide gel. In the control reaction, digestion of cap 0 RNA-
I, -II, -III or -IV with nuclease P1 generated m
7GpppG
(Figure 3B; lanes 1, 4, 7 and 10). Addition of VP39 prior
to nuclease P1 digestion shifts the m
7GpppG to a slower-
migrating band corresponding to the m
7GpppGm cap 1 struc-
ture (Figure 3B; lanes 2, 5, 8 and 11). Incubation of TbCom1
with any of the cap 0 RNA substrates did not alter the mobil-
ity of m7GpppG (Figure 3B; lanes 3, 6, 9 and 12), consistent
with the 2D TLC result that TbCom1 does not modify the
nucleoside at position 1. When cap 0 RNA-II, -III or -IV
was incubated with TbCom1, a novel radiolabeled species
Figure 2. Analysis of modified nucleosides by two-dimensional thin layer
chromatography. Reaction mixtures containing 50 mM Tris–HCl (pH 7.5), 5
mM DTT, 50 mM AdoMet and either 0.1 mMo f
32P-labeled cap 0 RNA-IV or
cap 1 RNA-IV were incubated for 30 min at 27 C in the presence or absence
of TbCom1. Mixtures were then digested with nuclease P1 and the products
were separated by 2D TLC as described in Materials and Methods. (A) cap 0
RNA-IV alone; (B) cap 0 RNA-IV with 4 pmol of TbCom1; (C) cap 1 RNA-
IV alone; (D) cap 1 RNA-IV with 4 pmol TbCom1. The positions of
guanosine 50 monophosphate (pG), methylated guanosine 50 monophosphate
(pGm), cap 0 dinucleoside (m
7GpppG) and cap 1 dinucleoside (m
7GpppGm)
are indicated.
Figure 3. TbCom1 transfers a methyl group to the 20-OH ribose moiety of the
2nd transcribed nucleoside. (A) Capped RNA substrates.
32P-labeled 35mer
cap 0 RNA substrates (RNA-I, -II, -III and -IV) were prepared by in vitro
transcription as described in Materials and Methods. Asterisks indicate
positions of
32P-labeled phosphates. One pmol of
32P-labeled cap 0 RNA-I,
-II, -III and IV as shown in (A) was incubated in 50 mM Tris–HCl (pH 7.5), 5
mM DTT, 50 mM AdoMet for 30 min at 27 C with either 4 pmol of vaccinia
VP39 (V: lanes 2, 5, 8 and 11) or TbCom1 (Tb; lanes 3, 6, 9 and 12). Control
reaction in the absence of methyltransferase are indicated by ( ). Reaction
products were digested with either nuclease P1 (B) or an RNase cocktail (C),
and products were resolved by 22% denaturing polyacrylamide gel. The
autoradiographs of the gels are shown.
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7GpppG and pG
(Figure 3B; lanes 6, 9 and 12). This radiolabeled species
likely corresponds to methylated pG (pGm), as the appear-
ance of this band was dependent on the addition of AdoMet
(data not shown). Furthermore, treatment with alkaline phos-
phatase after nuclease P1 digestion eliminated this species
(data not shown). The methyl transfer reaction was speciﬁc
to cap 0- and cap 1-terminated RNA. No detectable methyla-
tion was observed using an RNA substrate lacking the cap
N-7 methyl group (Figure 4A and data not shown).
To determine if modiﬁcation occurs at the 20-hydroxyl of
the ribose sugar, identical reactions were digested with an
RNase cocktail and the products were similarly resolved on
a polyacrylamide gel (Figure 3C). Note that methylation at
the 20-hydroxyl of the ribose will prevent digestion by
RNase resulting in the generation of a longer RNA fragment.
In a control reaction, RNase cleaves all four cap 0 RNA sub-
strates and generates m
7GpppGp (Figure 3C; lanes 1, 4, 7 and
10). The 30-phosphate shifts the migration of the cap dinu-
cleotide to a faster migrating band compared to m
7GpppG.
Methylation at the ﬁrst nucleoside by VP39 protects the
RNA from digestion between nucleosides 1 and 2, producing
the cap 1 products m
7GpppGmpUp (Figure 3C, lane 2) or
m
7GpppGmpGp (Figure 3C, lanes 5, 8 and 11). Note that
the difference in mobility of the cap 1 products is due to
the difference in nucleoside composition at position 2 (uracil
versus guanine). As expected, incubation of TbCom1 with
any of the cap 0 RNAs did not alter the mobility of
m
7GpppGp, further conﬁrming that methylation does not
take place on the ﬁrst transcribed nucleoside (Figure 3C,
lanes 3, 6, 9 and 12). When TbCom1 was incubated with
cap 0 RNA-III, a radiolabeled fragment which migrated
slower than m
7GpppGmpGp was detected (Figure 3C, lane
9). We predict that this TbCom1 speciﬁc fragment corre-
sponds to a methylated dinucleoside (G2mpG3p), derived
from nucleosides 2 and 3, that was resistant to RNase diges-
tion due to 20-O methylation. An identical radiolabeled prod-
uct was detected when cap 0 RNA-IV was incubated with
TbCom1 (Figure 3C, lane 12).
To address whether TbCom1 can methylate nucleosides
other than guanosine, we substituted the guanosine at position
2 of the cap 0 RNA-IV with either U or C to obtain
m
7GpppGpUpCp and m
7GpppGpCpUp RNAs. Incubation
of TbCom1 with these substrates followed by treatment
with RNase results in the formation of C2mpU3p and
U2mpC3p dinucleotide products, respectively (data not
shown). Furthermore, TbCom1 was capable of methylating
the 20-OH of the second transcribed nucleoside of either
cap 0- or cap 1-terminated poly(A) (data not shown). Taken
together, we surmise that TbCom1 is a cap-dependent,
sequence-independent, 20-O nucleoside methyltransferase
that speciﬁcally methylates the 2nd position of a transcribed
RNA.
Characterization of TbCom1 20-O methyltransferase
activity
The extent of nucleoside 20-O methylation on cap 0- and cap
1-RNA during a 30 min incubation at 27 C was proportional
to input TbCom1 (Figure 4A). In the linear range of enzyme
dependence, we estimate  1.5 pmol of cap 0 RNA can be
methylated by 1 pmol of input enzyme in 30 min. The spe-
ciﬁc activity for methylating cap 1 RNA was  5-fold higher
compared to cap 0 RNA. TbCom1 was unable to transfer the
methyl group to unmethylated capped RNA at the enzyme
concentration sufﬁcient to methylate the entire input cap 1
RNA. Methylation was dependent on AdoMet concentration
from 0.1 to 0.5 mM and the yield of methylated product pla-
teaued above 1 mM AdoMet (Figure 4B). Increasing concen-
tration of AdoHcy in the reaction inhibited product
formation;  75% inhibition was achieved at 200 mM Ado-
Hcy in the presence of 50 mM AdoMet (Figure 4C).
TbCom1 had a bell-shaped pH proﬁle with optimal activity
between pH 7.0–7.5 and activity declined sharply at acidic
pH (Figure 4D).
Specificity of TbCom1 binding to
m
7Gppp-terminated RNA
To investigate whether TbCom1 speciﬁcally interacts with
the cap structure, binding of TbCom1 to
32P-labeled cap 0
and unmethylated capped RNA was examined using a native
gel mobility shift assay (Figure 5A). Binding reactions were
performed in the absence of AdoMet to preclude conversion
Figure 4. Characterization of TbCom1 RNA 20-O methyltransferase activity.
(A) Protein titration. Reaction mixtures (10 ml) containing 50 mM Tris–HCl
(pH 7.5), 5 mM DTT, 50 mM AdoMet, 1 pmol of either cap 1-, cap 0- or
unmethylated cap RNA-IV, and TbCom1 as specified were incubated for 30
min at 27 C. Products were subjected to nuclease P1 digestion and analyzed
by TLC. The extent of 20-O methylation at position +2 is plotted as a function
of input enzyme. (B) AdoMet dependence. Reaction mixtures (10 ml)
contained 50 mM Tris–HCl (pH 7.5), 5 mM DTT, 0.1 mM of cap 0 RNA-IV,
4 pmol TbCom1, and AdoMet as indicated. Formation of pGm is plotted as a
function of AdoMet concentration. (C) Inhibition by AdoHcy. Reaction
mixtures (10 ml) contained 50 mM Tris–HCl (pH 7.5), 5 mM DTT, 0.1 mM
m
7GpppRNA, 50 mM AdoMet, 4 pmol TbCom1, with the indicated amounts
of AdoHcy. The extent of methylation is plotted as a function of AdoHcy
concentration. (D) pH dependency. Reaction mixtures (10 ml) containing 50
mM Tris buffer [either Tris–acetate (pH 5.0), 5.5, 6.5, 7.0 or Tris–HCl (pH
6.5, 7.0, 7.5, 8.0, 8.5, 9.0)], 5 mM DTT, 0.1 mM of cap 0 RNA-IV and 4 pmol
of TbCom1. The extent of 20-O methylation is plotted as function of pH.
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TbCom1 with the cap 0 RNA substrate resulted in the forma-
tion of a discrete protein–RNA complex that migrated more
slowly than the free RNA (Figure 5A). The abundance of
this complex increased in proportion to the amount of input
enzyme, with an apparent dissociation constant of  8n M
calculated based on (24). No speciﬁc complex was detected
when TbCom1 was incubated with GpppRNA (Figure 5A).
Thus, TbCom1 is capable of discriminating m
7GpppN from
GpppN at the substrate-binding step, conﬁrming the impor-
tance of the N-7 methyl-guanine in substrate recognition.
To assess the binding properties of TbCom1, we performed
competition assays with cap analogs. Either GTP, GpppG,
m
7GpppG or m
7GpppA at 0.1 mM or 1 mM was pre-
incubated with 0.1 mM
32P-labeled cap 0 RNA, followed by
addition of TbCom1. Neither GTP nor GpppG competed efﬁ-
ciently for binding by TbCom1 (Figure 5B). Both m
7GpppG
and m
7GpppA competed for cap 0 RNA-binding by TbCom1,
albeit only at high concentrations;  80% inhibition was
observed with 0.1 mM m
7GpppG and 40% inhibition was
observed with 0.1 mM m
7GpppA. These results demonstrate
that TbCom1 binds less avidly to cap analogues than to
m
7GpppG-terminated RNA and that the RNA chain is
required for a stable interaction.
Mutational analysis of TbCom1
We performed a mutagenesis analysis of TbCom1 to gain
insight into the structural and functional requirements for
the methyltransfer reaction. The structure of VP39 shows
that the active site is comprised of two ligand-binding pock-
ets: one for AdoMet and one for the m
7G cap (17–19). The
AdoMet-binding pocket in VP39 consists of a network of
hydrogen bonds and van der Waals interactions with the Ado-
Met adenine (Phe115 and Val116), ribose (Asp95, Arg97,
Val139 and Arg140) or methionine (Gln39, Tyr66, Gly72,
His74 and Asp138). The essential m
7G-binding pocket con-
sists of two aromatic residues (Tyr22 and Phe180), which
make base-stacking interactions with the guanine ring of
the m
7G cap. Additional hydrogen-bonding and van der
Waals interactions with m
7G are made by two acidic side-
chains (Asp182 and Glu233) and by the backbone carbonyl
of Tyr204. Of these 16 amino acids in VP39, 15 are either
identical or conserved in TbCom1 (Figure 1), suggesting
that TbCom1 may utilize a similar mechanism for recognition
of AdoMet and capped RNA substrates as VP39, even
though the enzymes differ in the positions they methylate
on the RNA.
We selected eight residues in TbCom1 for alanine-
substitution: three in the putative AdoMet-binding pocket
(His75, Asp142 and Arg144) and four in the putative cap-
binding pocket (Tyr18, Tyr187, Asp192 and Glu253) as indi-
cated by asterisks in Figure 1. In addition, we mutated
Val115, which is conserved among kinetoplastid Com1 pro-
teins but is absent in VP39. The mutant TbCom1 proteins
were expressed and puriﬁed in parallel with wild-type
TbCom1 (Figure 6A), and their methyltransferase activities
were compared to wild-type in the presence of 50 mM
AdoMet and 0.1 mM cap 1-terminated RNA-IV
(Figure 6B). The Y18A, H75A, D142A and R144A mutations
reduced the methyltransferase activity to <2% of wild-type
level. The Y187A and E253A proteins showed moderately
reduced levels of activity (16 and 22% of wild-type level,
respectively). In contrast, the V115A and D192A mutations
retain near wild-type activities.
To evaluate the nature of the defect in these mutant pro-
teins, their binding afﬁnities to m
7Gppp-terminated RNA
substrates were measured by gel mobility shift assay
(Figure 6C). The Y18A, Y187A and E253A mutations
show signiﬁcant reductions in binding to the capped RNA.
By comparing the extent of binding at equivalent concentra-
tions of proteins, we estimated that Y18A was reduced to 1%
of the wild-type level. The Y187A and E253A mutants had
5–10% of wild-type binding. The H75A and V115A mutants
Figure 5. TbCom1 binds specifically to m
7Gppp-terminated RNA. (A) Gel
mobility shift assay. Reaction mixtures (10 ml) contained either 0.1 mMo f
32P-labeled cap 0 RNA-IV (m
7GpppRNA) or unmethylated cap RNA-IV
(GpppRNA), with an increasing amount of TbCom1 (0.3, 0.6, 1.2 or
3.2 pmol, proceeding from left to right in the titration series). Control
reactions without protein are indicated as (--). Products were analyzed
by electrophoresis through a 6% native polyacrylamide gel. An autoradio-
gram of the dried gel is shown. The arrowhead to the right of the gel
indicates protein–RNA complex. (B) Competition assays. Reaction mixtures
contained 0.1 mMo f
32P-labeled cap 0 RNA-IV, 1 pmol of TbCom1 and
the indicated concentrations of either GTP, GpppG, m
7GpppA or m
7GpppG.
Control reactions without protein are indicated as ‘no competitor’. Protein–
RNA complex formed was plotted as a function of cap analogue
concentration.
Nucleic Acids Research, 2006, Vol. 34, No. 19 5599had slightly reduced binding ( 50% of the wild-type level),
whereas the D142A, R144A and D192A proteins maintained
strong binding to capped RNA. Thus the aromatic side-chains
(Tyr18 and Try187) and the acidic side-chain (Glu253) are
essential for recognition of capped RNA.
DISCUSSION
The mRNAs of kinetoplastid protozoans possess a unique cap
4 structure on the SL RNA, which is transferred to the 50 end
of all mRNAs by trans-splicing (6,11). While the enzymes
that catalyze cap 0 formation in T.brucei have been character-
ized (25–27), the 20-O nucleoside methyltransferase activit-
ies that lead to cap 4 have not been described. T.brucei
encodes 48 and 57 kDa proteins with similarity to the
vaccinia VP39 cap-dependent 20-O nucleoside RNA methyl-
transferase (14). We showed that the 48 kDa recom-
binant TbCom1 protein transfers a methyl group from
AdoMet to m
7GpppN-terminated RNA at the 20-OH position
of the second nucleoside of the transcribed RNA to form
m
7GpppNpNm. TbCom1 is capable of methylating either
cap 0- or cap 1-terminated RNA, indicating that methylation
at the second nucleoside occurs after cap 0 formation but can
take place prior to methylation at the ﬁrst nucleoside.
TbCom1 is the only cellular cap-dependent 20-O methyltrans-
ferase that has been characterized biochemically with a
unique speciﬁcity for methylating the second nucleoside of
the mRNA.
TbCom1 binds stably to a 35mer m
7GpppN-terminated
RNA, whereas like VP39, no complex was formed with
GpppN-terminated RNA (28). Thus TbCom1 is capable of
discriminating methylated versus unmethylated capped
RNA at the substrate-binding step. The apparent dissociation
constant of TbCom1 binding to methylated capped RNA was
about 8 nM, a value comparable to the afﬁnity of VP39 with
50mer m
7GpppN-RNA [Km ¼ 9.3 nM (28)]. We note that
m
7GpppA and m
7GpppG cap analogues are weak competi-
tors of TbCom1 binding to m
7GpppN-RNA, suggesting that
the enzyme requires a downstream RNA chain for stable
interaction. The fact that TbCom1 can bind to and methylate
RNA in a non-sequence dependent manner implies that 20-O
methylation can take place on RNAs other than the SL RNA,
such as snRNAs and polycistronic pre-mRNAs, although it is
not known whether polycistronic pre-mRNAs are capped.
Alternatively, an in vivo speciﬁcity for cap 4 modiﬁcation
to SL RNA is achieved by the recruitment of methyltrans-
ferase components to the site of SL RNA transcription,
as cap 4 formation appears to take place cotranscriptionally
during SL RNA synthesis (7).
We identiﬁed 6 amino acids (Tyr18, His75, Asp142,
Arg144, Tyr187 and Glu253) that are essential or important
for TbCom1 methyltransferase activity. Alanine-substitution
at His75, Asp142 and Arg144 in the putative AdoMet-
binding motif severely reduces TbCom1 methyltrans-
ferase activity, but the mutant proteins retain the ability to
bind to capped RNA. Based on the crystal structure of
VP39 complexed with AdoMet, TbCom1 His75 and
Asp142 (equivalent of VP39 His74 and Asp138, respectively)
may form hydrogen bonds with the terminal oxygen atoms
of the AdoMet methionine. The Arg144 in TbCom1 may
interact with the backbone nitrogen atom of the ribose ring
of AdoMet, analogous to Arg140 in VP39. Consistent with
our results, the D138A-R140A double mutant in VP39 was
deﬁcient for AdoMet-binding and methyltransferase activity
(29,30).
In addition to the VP39 structure, insight into the mecha-
nism of m
7G cap-recognition has been gained from the
atomic structures of human nuclear cap-binding complex
(CBC) and eIF4E complexed with either m
7GDP or methy-
lated cap analogues (31–33). While the overall structures of
these proteins differ signiﬁcantly, the guanine ring of the
Figure 6. Effects of alanine-substitution on TbCom1 methyltransferase
activity. (A) Protein purification. Aliquots (3 mg) of phosphocellulose
fractions of wild-type (WT) or the indicated alanine-mutants were analyzed
by SDS–PAGE. Polypeptides were visualized with Coomassie blue dye. The
positions and sizes (in kDa) of co-electrophoresed marker polypeptides are
indicated to the right. (B) Cap methyltransferase assays. Reaction mixtures
(10 ml) containing 50 mM Tris–HCl (pH 7.5), 5 mM DTT, 50 mM AdoMet,
0.1 mM
32P-labeled cap 1 RNA-IV and 4 pmol of wild-type (WT) or mutant
TbCom1. After incubation for 30 min at 27 C, samples were digested with
RNase cocktail and products were resolved on a 22% denaturing
polyacrylamide gel. An autoradiogram of the gel is shown. Labeled species
corresponding to m
7GpppGmpGp (cap 1) and m
7GpppGmpGmpGp (cap 2)
are indicated at the left. (C) Protein–RNA complex formation. The extent of
capped RNA-binding by wild-type and mutant TbCom1 proteins were
analyzed by gel mobility shift assay. Percentage of protein–RNA complex
formed was plotted as a function of input protein.
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with two aromatic residues in all three proteins: Tyr18/
Phe180 in VP39, Trp56/Trp102 in eIF4E and Tyr20/Try43
in CBP20 subunit of CBC. Perturbation of the aromaticity
by mutatagenesis of each of these proteins decreases the
afﬁnity, and in some cases the speciﬁcity, for the cap struc-
ture (19,33,34). We propose that TbCom1 utilizes analogous
base-stacking interactions for recognition of the m
7G moiety,
as mutation of the equivalent aromatic residues (Tyr18 and
Tyr187) led to reduced methyltransferase activity and
abolished capped RNA-binding. It is noteworthy that the
Y18A mutation had a more severe effect on binding to and
methylation of capped RNA than the Y187A mutation. This
is in contrast to VP39, where alanine substation at the ﬁrst
aromatic residue (Y22A) had a less dramatic effect on
methyltransferase activity than alanine-substitution at the
second aromatic residue (F180A) (19).
In addition to the base-stacking interactions, at least one
acidic side-chain in TbCom1 is essential for binding to
capped RNA. Alanine-substitution of Glu253 in TbCom1
led to a reduction in methyltransferase activity and cap-
speciﬁc binding. The corresponding acidic residues in VP39
(Glu233), eIF4E (Glu103) and the CBP20 subunit (Asp116)
interact with the N1 and/or N2 atom of the m
7G purine
ring via salt-bridges or hydrogen bonds (19,20,33–36).
Removal of these acidic side-chains decreased cap-speciﬁc
binding in all three proteins. We predict that the carboxyl
side-chain of Glu253 in TbCom1 interacts with the positively
charged m
7G moiety to enhance cap speciﬁcity. The Asp192
of TbCom1 corresponds to Asp182 of VP39. The Asp182
side-chain in VP39 forms a bi-dentate hydrogen bond with
the N2 atom of the cap guanine (19). However, the VP39
D182A mutation had no effect on methyltransferase activity
or binding to capped RNA. Similarly, we found that the
TbCom1 D192A mutant had wild-type methyltransferase
activity and cap-speciﬁc binding. Thus, it appears that the
asparagine side-chain does not signiﬁcantly contribute to
binding to the m
7G cap or catalysis in either VP39 or
TbCom1.
While our biochemical analysis of TbCom1 was in pro-
gress, genetic knockouts and RNAi-mediated knockdowns
of the 48 kDa TbCOM1 and 57 kDa T.brucei genes were gen-
erated (which were called TbMT48 and TbMT57, respec-
tively) (37–39). Neither the TbCOM1/TbMT48 nor TbMT57
knockouts, or the simultaneous knockdowns of both genes,
in procyclic T.brucei had effects on viability or trans-splicing.
Consistent with our biochemical data, TbCOM1/TbMT48-
deﬁcient cell lines lacked 20-O-ribose methylation at position
+2 on the SL RNA (38,39). In contrast, SL RNA isolated
from TbMT57 deﬁcient cell lines accumulated cap 2, imply-
ing that TbMT57 is involved in methylation at positions
+3 and/or +4 on the SL RNA (37,39). However, the enzym-
atic activity of the TbMT57 gene product has not been char-
acterized and thus it is not clear what is the substrate
requirement for its methyltransferase activity. Further struc-
tural and functional studies of TbCom1 and the TbMT57
gene product, as well as identiﬁcation of the methyltrans-
ferases responsible for SL RNA base modiﬁcations, should
provide a better understanding of how cap 4 modiﬁcations
are mechanistically coordinated and the role of cap 4 in kine-
toplastid parasite gene expression.
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